| RS2472724372 |
HGD
|
Health Risk |
Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472724534 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472724557 |
HGD
|
Health Risk |
Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472724789 |
SETD5
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2472724948 |
HGD
|
Health Risk |
Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472725001 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472725122 |
HGD
|
Health Risk |
Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472725187 |
SETD5
|
Health Risk |
Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2472725534 |
SETD5
|
Health Risk |
Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2472732399 |
GYG1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy type 2, Glycogen storage disease XV |
| RS2472735253 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2472735627 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2472735687 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Hematuria |
| RS2472740882 |
STAG1
|
Health Risk |
Likely pathogenic |
STAG1-related disorder, STAG1-related disorder |
| RS2472761454 |
CP
|
Health Risk |
Likely pathogenic |
Deficiency of ferroxidase, Deficiency of ferroxidase |
| RS2472761631 |
CLRN1
|
Health Risk |
Pathogenic |
— |
| RS2472761635 |
CLRN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 61, Neuronal ceroid lipofuscinosis |
| RS2472761786 |
CLRN1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 61, Retinitis pigmentosa 61 |
| RS2472761795 |
CLRN1
|
Health Risk |
Likely pathogenic |
— |
| RS2472761806 |
CLRN1
|
Health Risk |
Pathogenic |
— |
| RS2472762265 |
CP
|
Health Risk |
Pathogenic |
Deficiency of ferroxidase, Deficiency of ferroxidase |
| RS2472773829 |
CP
|
Health Risk |
Pathogenic |
Deficiency of ferroxidase, Deficiency of ferroxidase |
| RS2472785351 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472785645 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472786163 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472786418 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472786530 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472786583 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472794733 |
ADCY5
|
Health Risk |
Conflicting classifications of pathogenicity |
Morphological central nervous system abnormality, Morphological central nervous system abnormality |
| RS2472800703 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472800726 |
HGD
|
Health Risk |
Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472800910 |
HGD
|
Health Risk |
Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472801078 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472801382 |
HGD
|
Health Risk |
Pathogenic/Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472801424 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472801442 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472801605 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472802944 |
ILDR1
|
Health Risk |
Likely pathogenic |
Nonsyndromic genetic hearing loss, Nonsyndromic genetic hearing loss |
| RS2472804506 |
HGD
|
Health Risk |
Pathogenic/Likely pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472804530 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472804606 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472804843 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS2472821036 |
ILDR1
|
Health Risk |
Pathogenic |
— |
| RS2472824323 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2472827678 |
ILDR1
|
Health Risk |
Likely pathogenic |
Nonsyndromic genetic hearing loss, Nonsyndromic genetic hearing loss |
| RS2472828764 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2472830632 |
CLRN1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2472830767 |
CLRN1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 61, Retinitis pigmentosa 61 |
| RS2472830828 |
CLRN1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 61, Retinitis pigmentosa 61 |
| RS2472830838 |
CLRN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 61, Neuronal ceroid lipofuscinosis |
| RS2472831148 |
CLRN1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 61, Retinitis pigmentosa 61 |
| RS2472831238 |
CLRN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 61, Retinitis pigmentosa 61 |
| RS2472831271 |
CLRN1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 61, Retinitis pigmentosa 61 |
| RS2472831316 |
CLRN1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 61, Retinitis pigmentosa 61 |
| RS2472831349 |
CLRN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 61, Retinitis pigmentosa 61 |
| RS2472831512 |
CLRN1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 61, Retinitis pigmentosa 61 |
| RS2472832047 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2472840199 |
CP
|
Health Risk |
Likely pathogenic |
CP-related disorder, CP-related disorder |
| RS2472840538 |
CP
|
Health Risk |
Pathogenic |
Deficiency of ferroxidase, Deficiency of ferroxidase |
| RS2472844885 |
CP
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of ferroxidase, Deficiency of ferroxidase |
| RS2472852631 |
SETD5
|
Health Risk |
Likely pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2472854593 |
MRPS22
|
Health Risk |
Likely pathogenic |
Hypotonia with lactic acidemia and hyperammonemia, Hypotonia with lactic acidemia and hyperammonemia |
| RS2472859554 |
MRPS22
|
Health Risk |
Likely pathogenic |
— |
| RS2472863379 |
ADCY5
|
Health Risk |
Pathogenic |
— |
| RS2472872923 |
ADCY5
|
Health Risk |
Likely pathogenic |
— |
| RS2472878404 |
ARHGAP31
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2472899515 |
COPB2
|
Health Risk |
Likely pathogenic |
Osteoporosis, childhood- or juvenile-onset |
| RS2472905437 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2472919181 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2472919277 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2472919343 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2472919464 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2472920509 |
GATA2
|
Health Risk |
Pathogenic |
Monocytopenia with susceptibility to infections, Deafness-lymphedema-leukemia syndrome |
| RS2472920836 |
GATA2
|
Health Risk |
Likely pathogenic |
Monocytopenia with susceptibility to infections, Monocytopenia with susceptibility to infections |
| RS2472920937 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2472920958 |
GATA2
|
Health Risk |
Likely pathogenic |
Myelodysplastic syndrome, Myelodysplastic syndrome |
| RS2472921118 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2472921144 |
GATA2
|
Health Risk |
Likely pathogenic |
Monocytopenia with susceptibility to infections, Monocytopenia with susceptibility to infections |
| RS2472925192 |
GATA2
|
Health Risk |
Likely pathogenic |
— |
| RS2472929677 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2472929919 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2472929964 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2472930152 |
GATA2
|
Health Risk |
Likely pathogenic |
Monocytopenia with susceptibility to infections, Monocytopenia with susceptibility to infections |
| RS2472930176 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2472930436 |
GATA2
|
Health Risk |
Pathogenic |
Monocytopenia with susceptibility to infections, Deafness-lymphedema-leukemia syndrome |
| RS2472930871 |
GATA2
|
Health Risk |
Likely pathogenic |
— |
| RS2472931166 |
GATA2
|
Health Risk |
Pathogenic |
Monocytopenia with susceptibility to infections, Deafness-lymphedema-leukemia syndrome |
| RS2472931721 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2472932040 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2472932149 |
GATA2
|
Health Risk |
Pathogenic |
Monocytopenia with susceptibility to infections, Deafness-lymphedema-leukemia syndrome |
| RS2472932712 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2472934198 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2472934556 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2472934740 |
GATA2
|
Health Risk |
Pathogenic |
Monocytopenia with susceptibility to infections, Deafness-lymphedema-leukemia syndrome |
| RS2472935134 |
GATA2
|
Health Risk |
Likely pathogenic |
Monocytopenia with susceptibility to infections, Monocytopenia with susceptibility to infections |
| RS2472936713 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2472937712 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS2472939479 |
UGT1A1
|
Health Risk |
Pathogenic |
— |
| RS2472941300 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2472944256 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
SETD5-related disorder, SETD5-related disorder |